Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

DOI

10.1093/eurheartj/ehs215

Type

Journal article

Publication Date

2012-10-01T00:00:00+00:00

Volume

33

Pages

2569 - 2619

Total pages

50

Keywords

Antifibrinolytic Agents, Anxiety, Arrhythmias, Cardiac, Biomedical Research, Cardiac Imaging Techniques, Cardiomyopathies, Cardiotonic Agents, Coronary Artery Bypass, Dyspnea, Electrocardiography, Emergency Medical Services, Emergency Treatment, Exercise Therapy, Fibrinolytic Agents, Forecasting, General Practice, Heart Failure, Hemodynamics, Hospitalization, Humans, Hyperglycemia, Long-Term Care, Myocardial Infarction, Myocardial Reperfusion, Out-of-Hospital Cardiac Arrest, Pain, Percutaneous Coronary Intervention, Platelet Aggregation Inhibitors, Risk Assessment, Risk Reduction Behavior, Time-to-Treatment